AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Gender Based Comparison of the Effects of Sensory Modulated Graded Weight Bearing Physiotherapy In Adults With Knee Osteoarthritis

RecruitingNAAges 40 Years - 60 YearsAllShifa Tameer-e-Millat University
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

This comparative experimental study aims to evaluate the effectiveness of Sensory-Modulated Graded Weight-Bearing Physiotherapy (SMGWBP) in patients with knee osteoarthritis and compare treatment outcomes between male and female participants. Participants will receive a 6-week physiotherapy program with assessments conducted at baseline (pre-intervention), mid-intervention (3 weeks), and post-intervention (6 weeks) using validated outcome measures.

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion criteria * Participants are eligible for inclusion if they meet the following criteria: * Age between 40 and 60 years. * Diagnosed with Grade II or Grade III Knee Osteoarthritis according to Kellgren-Lawrence Classification. * Ability to ambulate independently without assistive devices. * Mild to moderate pain intensity with a Visual Analogue Scale score less than seven. * Ability to understand and follow instructions. * Willingness to participate and provide written informed consent. Exclusion Criteria * Participants are excluded if they meet any of the following criteria: * History of knee surgery within the previous six months. * Neurological disorders affecting balance, gait, or proprioception. * Severe cardiovascular disease limiting participation in exercise. * Rheumatoid arthritis or other inflammatory arthritic conditions. * Severe cognitive impairment. * Any medical condition that contraindicates participation in rehabilitation exercises.
๐Ÿ’Š

What it tests

  • Sensory-Modulated Graded Weight-Bearing Physiotherapy
๐Ÿ“

Where

1 site
T.H.Q hospital
Gujar Khan, Pakistan
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy